Categories
Anti Cancer Breakthrough Therapies Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Guidance Cancer Treratments Drug Repurposing & Innovation Fenbendazole Integrative Oncology Insights Ivermectin Mebendazole Non-Chemo Cancer Treatments Repurposed Drug Studies

Fenbendazole Dosage Guide for Humans 2026

Fenbendazole is one of the most talked-about topics in cancer communities heading into 2026 — and we’re adding our voice to the conversation. Watch our latest video where we share our take on FBZ, then grab our free downloadable dosage guideline to keep on hand.

Categories
Anti Cancer Cancer Research & Clinical Evidence Cancer Research Literacy Cancer Treatment Cancer Treatment Claims & Critical Analysis Cancer Treatment Options Cancer Treratments Colorectal Cancer Critical Evaluation of Cancer Research Drug Repurposing & Innovation Fenbendazole Genetic Testing Gut-Microiome Integrative Oncology Insights Joe Tippins Non-Chemo Cancer Treatments Repurposed Drug Studies

Does Fenbendazole Really Treat Colorectal Cancer? What the 2026 Evidence Actually Shows Beyond the Joe Tippens Viral Story

This article from Courage Against Cancer evaluates the potential of fenbendazole, a veterinary drug, as a treatment for human colorectal cancer. Despite promising preclinical evidence, there are no conclusive human trials proving its efficacy. Patients are urged to discuss its use with oncologists, as risks such as liver toxicity exist.

Categories
Anti Cancer Cancer Research Literacy Cancer Support & Encouragement Cancer Treatment Cancer Treatment Guidance Cancer Treatment Options Colorectal Cancer Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Integrative Oncology Insights Ivermectin Joe Tippins Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies

The Joe Tippens Story: How a Veterinary Dewormer Became a Viral Cancer Cure Claim

The article from Courage Against Cancer discusses Joe Tippens, whose recovery from small cell lung cancer was linked to fenbendazole, a veterinary dewormer. It emphasizes that his case lacks clinical validation and critical context, such as concurrent immunotherapy, highlighting the importance of distinguishing personal narratives from scientific evidence in cancer treatment discussions.

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment Options chemotherapy Clinical Trials & Cancer Treatment FAQ

What factors determine if I’m a candidate for clinical trials?

Clinical trial eligibility is determined by factors such as cancer type, stage, treatment history, overall health, and age. Trials vary in their requirements, and patients are encouraged to consult their medical team for guidance. Resources like ClinicalTrials.gov can assist in exploring available options. Always discuss participation with healthcare providers.

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cancer Wellness Protocols chemotherapy Clinical Trials & Cancer Treatment Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study immunotherapy Ivermectin Mebendazole Non-Chemo Cancer Treatments Research & Science Research News & Updates

What questions should cancer patients ask their oncologist before considering off-label ivermectin based on this study?

The study by Hulscher et al. (2026) raised concerns regarding the use of ivermectin for cancer treatment, being observational and self-reported without rigorous trials. Potential conflicts of interest and unresolved questions about data integrity highlight the need for caution. Patients should discuss these issues with their oncologist and consider ongoing clinical trials.

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cluster Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Health & Wellness Hulscher Study Ivermectin Mebendazole

What is an ‘expression of concern’ from a scientific Hulscher 2026 ivermectin study financially connected to The Wellness Company?

An expression of concern (EOC) is a warning from a journal about potential issues in a study’s integrity without retracting it. Anticancer Research issued an EOC for Hulscher et al. (2026), citing data verifiability and ethical concerns, particularly due to conflicts of interest and reliance on self-reported outcomes without rigorous controls.

Categories
Anti Cancer Breakthrough Therapies cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cancer Treatment Options Cancer Wellness Protocols cancer-prevention chemotherapy Clinical Trials & Cancer Treatment Evaluating Cancer Treatment Claims FAQ Health & Wellness immunotherapy Integrative Oncology Insights Non-Chemo Cancer Treatments

How are newer cancer treatments different from traditional chemotherapy?

Newer cancer treatments, including targeted therapies and immunotherapies, attack cancer cells more precisely than traditional chemotherapy, which affects all rapidly dividing cells. These innovative approaches often result in fewer side effects and improved survival rates for some cancers. Treatment plans may combine old and new methods for optimal outcomes.

Categories
Anti Cancer Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cancer Treatment Options Cancer Wellness Protocols cancer-prevention chemotherapy Clinical Trials & Cancer Treatment Evaluating Cancer Treatment Claims Health & Wellness immunotherapy

Should I get a second opinion before starting cancer treatment?

Seeking a second opinion for cancer treatment is advised by major medical organizations, as it can confirm diagnoses, explore treatment options, and provide peace of mind. Research shows recommendations may change in 10-30% of cases. Patients are encouraged to obtain their medical records, and reputable oncologists support second opinions.

Categories
Anti Cancer Biome Health Brain Fog Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment Guidance Cancer Wellness Protocols Clinical Trials & Cancer Treatment Critical Evaluation of Cancer Research Genetic Testing Genome Sequencing Gut Biome Gut-Microiome Gut–Immune–Brain Axis Health & Wellness immunotherapy integrative-oncology Microbiome Natural Treatments Non-Chemo Cancer Treatments

What is precision medicine in cancer treatment?

Precision medicine tailors cancer treatment using genetic testing and tumor analysis, moving away from the traditional one-size-fits-all approach. By assessing a cancer’s unique characteristics, doctors can recommend effective therapies, improving outcomes and minimizing side effects. Current tests and applications focus on various cancer types, offering personalized treatment strategies.

Categories
Anti Cancer Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cancer Treatment Options cancer-prevention Evaluating Cancer Treatment Claims FAQ immunotherapy Research & Science

Can cancer be cured with treatment?

Many cancers can be cured, especially if detected early, with success rates varying by type and individual factors. Effective treatments have improved outcomes, but some cancers may only be managed as chronic conditions. Consult your oncologist for personalized information, as well as continuous follow-up and support resources are essential for survivorship.